Bilirubin, a Cardiometabolic Signaling Molecule

被引：94

作者：

Hinds, Terry D., Jr. ^{[1
]}

Stec, David E. ^{[2
]}

机构：

[1] Univ Toledo, Dept Physiol & Pharmacol, Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA

[2] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Mississippi Ctr Obes Res, Jackson, MS 39216 USA

来源：

HYPERTENSION | 2018年 / 72卷 / 04期

关键词：

ACTIVATED RECEPTOR-ALPHA; HUMAN BILIVERDIN REDUCTASE; TYPE-2; DIABETES-MELLITUS; INCREASES INSULIN SENSITIVITY; II-DEPENDENT HYPERTENSION; SERUM BILIRUBIN; HEPATIC STEATOSIS; GILBERTS-SYNDROME; MODERATE HYPERBILIRUBINEMIA; CARDIOVASCULAR-DISEASE;

D O I：

10.1161/HYPERTENSIONAHA.118.11130

中图分类号：

R6 [外科学];

学科分类号：

100210 [外科学];

摘要：

[No abstract available]

引用

页码：788 / 795

页数：8

共 92 条

[81]

Peroxisome proliferator-activated receptor (PPAR)α activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue -: Comparison of activation of PPARα, PPAR-γ, and their combination [J].

Tsuchida, A ;

Yamauchi, T ;

Takekawa, S ;

Hada, Y ;

Ito, Y ;

Maki, T ;

Kadowaki, T .

DIABETES, 2005, 54 (12) :3358-3370

[82]

Fenofibrate prevents the development of angiotensin II-dependent hypertension in mice [J].

Vera, T ;

Taylor, M ;

Bohman, Q ;

Flasch, A ;

Roman, RJ ;

Stec, DE .

HYPERTENSION, 2005, 45 (04) :730-735

[83]

Moderate hyperbilirubinemia improves renal hemodynamics in ANG II-dependent hypertension [J].

Vera, Trinity ;

Stec, David E. .

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2010, 299 (04) :R1044-R1049

[84]

Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice [J].

Vera, Trinity ;

Granger, Joey P. ;

Stec, David E. .

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2009, 297 (03) :R738-R743

[85]

Vogel ME, 2016, INFLAMM CELL SIGNAL, V3, pe1178

[86]

Bilirubin Prevents Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor-Deficient Mice by Inhibiting Endothelial VCAM-1 and ICAM-1 Signaling [J].

Vogel, Megan E. ;

Idelman, Gila ;

Konaniah, Eddy S. ;

Zucker, Stephen D. .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (04)

[87]

A Selective Peroxisome Proliferator-Activated Receptor α Agonist, CP-900691, Improves Plasma Lipids, Lipoproteins, and Glycemic Control in Diabetic Monkeys [J].

Wagner, Janice D. ;

Shadoan, Melanie K. ;

Zhang, Li ;

Ward, Gina M. ;

Royer, Lori J. ;

Kavanagh, Kylie ;

Francone, Omar L. ;

Auerbach, Bruce J. ;

Harwood, H. James, Jr. .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (03) :844-853

[88]

Protection from age-related increase in lipid biomarkers and inflammation contributes to cardiovascular protection in Gilbert's syndrome [J].

Wallner, Marlies ;

Marculescu, Rodrig ;

Doberer, Daniel ;

Wolzt, Michael ;

Wagner, Oswald ;

Vitek, Libor ;

Bulmer, Andrew C. ;

Wagner, Karl-Heinz .

CLINICAL SCIENCE, 2013, 125 (5-6) :257-264

[89]

Bilirubin Decreases Macrophage Cholesterol Efflux and ATP-Binding Cassette Transporter A1 Protein Expression [J].

Wang, Dongdong ;

Tosevska, Anela ;

Heiss, Elke H. ;

Ladurner, Angela ;

Moelzer, Christine ;

Wallner, Marlies ;

Bulmer, Andrew ;

Wagner, Karl-Heinz ;

Dirsch, Verena M. ;

Atanasov, Atanas G. .

JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (05)

[90]

Biliverdin reductase and bilirubin in hepatic disease [J].

Weaver, Lauren ;

Hamoud, Abdul-rizaq ;

Stec, David E. ;

Hinds, Terry D., Jr. .

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2018, 314 (06) :G668-G676

← 1 2 3 4 5 6 7 8 9 10 →